Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

Béïque, Jean-Claude, Imad, Mays, Mladenovic, Ljiljana, Gingrich, Jay A., Andrade, Rodrigo·2007·Proceedings of the National Academy of Sciences

Cited by (229)

Items 201–229 of 229

  1. Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens
    Matteo Lazzaretti, Gian Mario Mandolini, Alfredo Carlo Altamura, Paolo Brambilla · 2018 · Springer eBooks
  2. Neurobiologische Grundlagen der Wirkung von Psychedelika
    Franz X. Vollenweider, Katrin H. Preller · 2016 · Springer eBooks
  3. Receptores Monoaminérgicos en Corteza Prefrontal: Mecanismo de Acción de Fármacos Antipsicóticos
    Noemí Santana Ramos · 2007 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  4. Psychedelic Drugs
    David E. Nichols, Charles David Nichols · 2021 · Springer eBooks
  5. The classic psychedelic DOI induces a persistent desynchronized state in medial prefrontal cortex
    Randall J. Olson, Lowell Bartlett, Alex Sonneborn, Zachary Bretton-Granatoor, Ayesha Firdous, Alexander Z. Harris, Atheir I. Abbas · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Efeito do chá de ayahuasca sobre o comportamento de ratos Wistar no campo aberto e labirinto em cruz elevado e sobre a expressão de EAAC1 no hipocampo e córtex pré-frontal
    Luana Gonçalves Zamarrenho · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  7. Regulation of neuronal excitability: New mechanisms for slow afterhyperpolarization activation and modulation
    Claudio A. Villalobos · 2010 · Human Biology
  8. Efectos de los antagonistas NMDA sobre la neurotransmisión serotonérgica y glutamatérgica en la corteza prefrontal. Mecanismo de acción de los fármacos antipsicóticos
    Javier López Gil · 2009 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  9. Role of the cortex in the regulation of anxiety states
    Noelia Weisstaub, Caitlin E. McOmish, James B. Hanks, Jay A. Gingrich · 2010 · Cambridge University Press eBooks
  10. Understanding the causes of anxiety
    Helen Blair Simpson, Yuval Neria, Roberto Lewis‐Fernández, Franklin Schneier · 2010 · Cambridge University Press eBooks
  11. Organização das projeções do córtex pré-fontral para o núcleo dorsal da rafe no rato.
    Luciano Gonçalves · 2008
  12. The Role of LMO4 in the Regulation of Hippocampal and Amygdalar Synaptic Function
    Zhaohong Qin · 2013 · uO Research (University of Ottawa)
  13. The role of serotonin in cortical excitability and network dynamics
    Pavel A. Puzerey · 2015 · OhioLink ETD Center (Ohio Library and Information Network)
  14. Organotypic Slices and Biolistic Transfection for the Study of Serotonin Receptor Function in CNS Neurons
    Kelly M. McGregor, Jean-Claude Béïque, Rodrigo Andrade · 2014 · Neuromethods
  15. Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention
    Matthew J. Baggott · 2010 · eScholarship (California Digital Library)
  16. Lysergic Acid Diethylamide and Mescaline
    2014 · John Wiley & Sons, Inc. eBooks
  17. Psychedelic Drugs
    David E. Nichols, Charles David Nichols · 2021 · Springer eBooks
  18. Other psychedelics
    James Linden, Daniel Robin · 2023
  19. Psychoactive substances in psychotherapy - A vision for the future? – A systematic review on Psilocybin
    Jenny Tetem, Tamara Fischmann, Tim Julian Möller · 2023 · PsyArXiv (OSF Preprints)
  20. Advancements in psychedelic research: Effects, mechanisms, and therapeutic potential as emerging antidepressants
    Xianqiang Zhang, De-Nong Liu, Qing-Shan Miao, Xu Cai, Lu-Xin Zong, Yu-Kun Hou, Jing Xiong · 2025 · Pharmacology Biochemistry and Behavior
  21. Rôle des récepteurs 5-HT2A et 5-HT6 du cortex préfrontal dans la modulation de la transmission synaptique, la plasticité et la cognition
    Coralie Berthoux · 2017 · theses.fr (ABES)
  22. Hyperreligiosité post-lésionnelle et rétablissement du sentiment de soi par la psychothérapie narrative médiatisée : diagnostic et traitement psychothérapique des syndromes avec hyperreligiosité secondaires à un traumatisme cranio-cérébral sévère chez des sujets en situation de handicap cognitif
    Maria Pilar Galiana Abal · 2017
  23. Mu-opioid and nociceptin receptors show divergent, cell-type-specific actions in the mesocorticolimbic reward system in opioid use disorder
    Marie‐Charlotte Allichon, Jeanne Espinosa, Rebecca H. Cole, Mei-Chuan Ko, Peter Vanhoutte, Max E. Joffe · 2026 · Frontiers in Cellular Neuroscience
  24. Psychedelics and the thalamocortical system: A scoping review
    Sofía Villalba, Agustín Martínez Christensen, Lucia Di Costanzo, Pablo Torterolo, Ignacio Carrera, Francisco J. Urbano, Verónica Bisagno · 2026 · Pharmacology Biochemistry and Behavior
  25. Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
    Kristjan Kaup, Javier Hidalgo Jiménez, Jaan Aru · 2026 · Neuroscience & Biobehavioral Reviews
  26. Multiplexing of functionally distinct inputs by intrinsic modulation of spike timing in a monoaminergic nucleus
    Michael B. Lynn, Leonard Maler, Jean-Claude Béïque · 2026 · Cell Reports
  27. Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis
    Renan Massanobu Maekawa, Lorena T. L. Guerra, Bianca Villanova, Caio César de Paula, Anna Beatriz Vicentini, Lucas Silva Rodrigues, José Augusto Silva Reis, Giordano Novak Rossi, José Carlos Bouso, Jaime E. C. Hallak et al. · 2026 · Journal of Clinical Psychopharmacology
  28. 5-HT2A receptor activation induces CB1-dependent presynaptic inhibitory long-term depression in the nucleus accumbens core
    Camila Estay‐Olmos, Koyam Morales-Weil, Juan Ahumada, Ramón Sotomayor‐Zárate, Marco Fuenzalida · 2026 · Frontiers in Pharmacology
  29. Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice
    Landon M. Klein, Jared M. Kopelman, Richard F. Sharp, Susan B. Powell, Mark A. Geyer, Jared W. Young, Adam L. Halberstadt · 2026 · Psychopharmacology